PCIBo — PCI Biotech Holding ASA Cashflow Statement
0.000.00%
Last trade - 00:00
- NOK65.77m
- NOK35.71m
- NOK2.99m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -88.7 | -72.2 | -88.4 | -55.1 | -20.3 |
Depreciation | |||||
Non-Cash Items | 2.35 | -2.11 | 15.5 | -1.41 | 2 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.97 | -5.25 | 2.04 | -8.94 | 2.97 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -83.5 | -77.4 | -68.3 | -59 | -15 |
Capital Expenditures | -5.41 | -3.92 | -0.341 | 0 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.78 | 0 | — | — | — |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.63 | -3.92 | -0.341 | 0 | 0 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.526 | -0.352 | -0.673 | -0.678 | -0.442 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -88.2 | -73.1 | -71.8 | -59.5 | -15.4 |